Comm Eye Health South Asia Vol. 37 No. 125 2025. Published online 25 March, 2025
Maculopathies made simple

Macular diseases are on the increase worldwide, thanks to the rapid rise in diabetes, ageing populations, and the increasing number of people with myopia, all of which lead to a greater number of people being affected by diabetic macular oedema, age-related macular degeneration, and myopic maculopathy, respectively. These conditions are all treatable, especially if patients are identified and referred appropriately.
- Maculopathies made simple
- Clinical examination of the macula
- Age-related macular degeneration (AMD): an introduction
- Diabetic macular oedema (DMO): an introduction
- Anti-VEGF treatment for macular conditions
- Surgical maculopathies: epiretinal membranes and full-thickness macular holes
- Optical coherence tomography: an introduction
- Management of myopic traction maculopathy
- Biosimilars for anti-VEGF treatment of macular diseases: country and region reports
- Availability and affordability of anti-VEGF biosimilars for the treatment of age-related macular degeneration and diabetic macular oedema in Sri Lanka
- Working with patients affected by macular eye conditions
- Key community Eye health messages
- मैकुलोपैथी को समझें
- மாகுலோபதிகள் எளிமையாக்கப்பட்டன